Evidence map›Paper›PMID 39271118›Full record

ArticleNucleic acids research2024

Using nucleolytic toxins as restriction enzymes enables new RNA applications.

Ulli Rothweiler, Sigurd Eidem Gundesø, Emma Wu Mikalsen, Steingrim Svenning, Mahavir Singh, Francis Combes, Frida J Pettersson, Antonia Mangold, Yvonne Piotrowski, Felix Schwab and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ulli RothweilerArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.ORCID 0000-0003-2802-7558
Sigurd Eidem GundesøArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.ORCID 0009-0003-0976-5333
Emma Wu MikalsenArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.
Steingrim SvenningArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.ORCID 0000-0001-5168-464X
Mahavir SinghMolecular Biophysics Unit, Indian Institute of Science, Bengaluru 560012, India.ORCID 0000-0003-1251-8248
Francis CombesDepartment of Biotechnology and Nanomedicine, SINTEF AS, Richard Birkelands vei 3, N-7034 Trondheim, Norway.ORCID 0000-0001-5926-4957
Frida J PetterssonDepartment of Biotechnology and Nanomedicine, SINTEF AS, Richard Birkelands vei 3, N-7034 Trondheim, Norway.
Antonia MangoldArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.
Yvonne PiotrowskiArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.
Felix SchwabArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.
Olav LanesArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.
Bernd Ketelsen StribernyArcticZymes Technologies ASA, Sykehusveien 23, 9019 Tromsø, Norway.ORCID 0009-0001-6548-6211

Funding

Research Council of Norway 346796
6 · The paper itself

Abstract

Over the past five decades, DNA restriction enzymes have revolutionized biotechnology. While these enzymes are widely used in DNA research and DNA engineering, the emerging field of RNA and mRNA therapeutics requires sequence-specific RNA endoribonucleases. Here, we describe EcoToxN1, a member of the type III toxin-antitoxin family of sequence-specific RNA endoribonucleases, and its use in RNA and mRNA analysis. This enzyme recognizes a specific pentamer in a single-stranded RNA and cleaves the RNA within this sequence. The enzyme is neither dependent on annealing of guide RNA or DNA oligos to the template nor does it require magnesium. Furthermore, it performs over a wide range of temperatures. With its unique functions and characteristics, EcoToxN1 can be classified as an RNA restriction enzyme. EcoToxN1 enables new workflows in RNA analysis and biomanufacturing, meeting the demand for faster, cheaper, and more robust analysis methods.

Indexed as

EndoribonucleasesRNABacterial ToxinsRNA, MessengerSequence Analysis, RNABacterial ToxinsEndoribonucleasesRNARNA, Messenger

Identifiers

PMID39271118
PMCPMC11472045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.